- $558.27m
- $468.05m
- $75.51m
- 58
- 39
- 71
- 57
R2020 June 30th | R2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F |
Standards: | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 2.17 | 7.9 | 59 | 75.5 |
Selling / General / Administrative Expenses | ||||
Depreciation and Amortization | ||||
Unusual Expense / Income | ||||
Other Operating Expenses | ||||
Total Operating Expenses | 3.85 | 8.42 | 58.7 | 232 |
Operating Profit | -1.68 | -0.524 | 0.295 | -157 |
Gain / Loss on Sale of Assets | ||||
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | -2.14 | -59.2 | -417 | -169 |
Provision for Income Taxes | ||||
Net Income After Taxes | -2.14 | -60.4 | -420 | -172 |
Net Income Before Extraordinary Items | ||||
Net Income | -2.14 | -60.4 | -420 | -172 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | -2.14 | -60.4 | -420 | -172 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | -0.039 | -1.09 | -10.2 | -1.84 |
Dividends per Share |